The convergence of technology, digitalization, additive manufacturing, machine learning, and AI continue to have a huge impact on the healthcare and pharmaceutical industries. The Life Science industry is poised to deliver breakthrough innovations at a rate, and cost, never thought possible.
Clinical trials heavily use subjective scoring methods for disease severity measurements. AI can help devise new consistent and objective disease severity measures. These novel measures and scores are alternatively extracted from wearable sensor data of patients instead of the opinion of clinicians. AI and ML algorithms can extract consistent patient observation from sensors while ignoring the inter-patient variabilities in sensor data.
On the other side, pharma operations need AI to forecast drug demand. Clinical test data and rapidly published medical research literature naturally calls for Deep Neural Nets based information classification, extraction, and summarization.
The Embassy of Pakistan invites you to a Tech Talk focused on these issues. The presenter Mr. Muhammad Tariq, will share some of his team’s recent success stories of AI with biotech and pharma clients.
The event will be livestreamed on the official Facebook page of the Embassy.